ValueAct Holdings’s Bausch Health BHC Stock Holding History

ValueAct Holdings’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,341,265	Closed	-$120M	–	13
2022 Q2	$120M	Sell	14,341,265 -89,636	-0.6%	-$1.25M	1.91%	10
2022 Q1	$330M	Sell	14,430,901 -1,185,860	-8%	-$29M	4.54%	8
2021 Q4	$431M	Sell	15,616,761 -2,324,842	-13%	-$62.2M	4.86%	7
2021 Q3	$500M	Hold	17,941,603	–	–	5.79%	7
2021 Q2	$526M	Hold	17,941,603	–	–	5.83%	7
2021 Q1	$569M	Hold	17,941,603	–	–	6.65%	7
2020 Q4	$373M	Buy	17,941,603 +10,009	+0.1%	+$187K	4.33%	9
2020 Q3	$279M	Hold	17,931,594	–	–	3.92%	8
2020 Q2	$328M	Hold	17,931,594	–	–	3.75%	9
2020 Q1	$278M	Hold	17,931,594	–	–	3.99%	9
2019 Q4	$537M	Hold	17,931,594	–	–	5.43%	8
2019 Q3	$392M	Hold	17,931,594	–	–	4.23%	9
2019 Q2	$452M	Sell	17,931,594 -101,555	-0.6%	-$2.41M	4.72%	8
2019 Q1	$445M	Hold	18,033,149	–	–	4.9%	8
2018 Q4	$333M	Hold	18,033,149	–	–	4.15%	8
2018 Q3	$463M	Hold	18,033,149	–	–	4.55%	8
2018 Q2	$419M	Buy	18,033,149 +21,612	+0.1%	+$447K	3.79%	11
2018 Q1	$287M	Buy	18,011,537 +1,510	+0%	+$28.1K	2.87%	10
2017 Q4	$374M	Hold	18,010,027	–	–	3.79%	10
2017 Q3	$258M	Buy	18,010,027 +12,803	+0.1%	+$194K	2.59%	12
2017 Q2	$311M	Hold	17,997,224	–	–	2.78%	12
2017 Q1	$199M	Buy	17,997,224 +3,002,963	+20%	+$41.3M	1.66%	12
2016 Q4	$218M	Hold	14,994,261	–	–	1.79%	12
2016 Q3	$368M	Hold	14,994,261	–	–	3.2%	10
2016 Q2	$302M	Hold	14,994,261	–	–	2.74%	10
2016 Q1	$394M	Hold	14,994,261	–	–	3.94%	9
2015 Q4	$1.52B	Hold	14,994,261	–	–	10.55%	2
2015 Q3	$2.67B	Hold	14,994,261	–	–	15.55%	2
2015 Q2	$3.33B	Sell	14,994,261 -4,389,616	-23%	-$973M	17.54%	1
2015 Q1	$3.85B	Hold	19,383,877	–	–	21.28%	1
2014 Q4	$2.77B	Buy	19,383,877 +460,000	+2%	+$61.9M	17.38%	2
2014 Q3	$2.48B	Hold	18,923,877	–	–	16.64%	2
2014 Q2	$2.39B	Hold	18,923,877	–	–	17.64%	2
2014 Q1	$2.49B	Hold	18,923,877	–	–	18.84%	2
2013 Q4	$2.22B	Hold	18,923,877	–	–	18.37%	2
2013 Q3	$1.97B	Hold	18,923,877	–	–	17.82%	2
2013 Q2	$1.63B	Buy	+18,923,877	New	+$1.49B	16.73%	3

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

ValueAct Holdings's BHC Position: Q3 2022 in Review

ValueAct Holdings sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 14,341,265 shares — an estimated $120M sold.

ValueAct Holdings first reported a position in BHC in Q2 2013 and held it in 37 quarters. The position peaked at $3.85B in Q1 2015. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

ValueAct Holdings reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
ValueAct Holdings sold 14,341,265 Bausch Health shares in Q3 2022, an estimated $120M.
ValueAct Holdings first reported a position in Bausch Health in Q2 2013 and held it in 37 quarters.
ValueAct Holdings's Bausch Health position peaked at $3.85B in Q1 2015.
283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on ValueAct Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.